Published in
American Society of Hematology, Blood, 17(126), p. 1996-2004, 2015
DOI: 10.1182/blood-2015-05-644039
Links
- American Society of Hematology | PDF
- ORCID
- ORCID
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net]
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [eprints.whiterose.ac.uk] | PDF
Tools
Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging System
Journal article published in 2015 by
Rowan Kuiper,
Mark van Duin,
Martin H. van Vliet,
Annemiek Broijl,
Bronno van der Holt 
,
Laila El Jarari,
Laila el Jarari,
Erik H. van Beers,
George Mulligan,
Hervé Avet-Loiseau ,
Walter M. Gregory,
Gareth Morgan,
Hartmut Goldschmidt,
Henk M. Lokhorst,
Pieter Sonneveld
,
Laila El Jarari,
Laila el Jarari,
Erik H. van Beers,
George Mulligan,
Hervé Avet-Loiseau ,
Walter M. Gregory,
Gareth Morgan,
Hartmut Goldschmidt,
Henk M. Lokhorst,
Pieter Sonneveld
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key PointsCombination of ISS and the EMC92 gene classifier is a novel clinically applicable risk classification for survival in multiple myeloma. ISS has clear independent additive prognostic value in combination with GEP classifiers or FISH markers.